25.100
−3,09%
2026-10-16
Fundamental Analysis
56 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +41.4% | -13.3% | 1 / 3 | +54.7% | -15.94 pp | -1.17 pp | +20.9% | 0.00 | 7.03 | 51,0 | +54,7% | 6,4 | +41,4% | 7.03 | 7.39 | −4,8% |
| Pts | 8 | 0 | 4 | 12 | 0 | 4 | 12 | 12 | 8 | |||||||
Valuation annotation:Price: 25.100 (close price on 2026-10-16)EPS (TTM): 3.569
Financial charts
1.Revenue & growth
VND bn51,0Q2/26
1.Revenue & growth
VND bn51,0Q2/26
2.Profit & growth
VND bn6,36Q2/26
3.Profit mix (Penman)
VND bn17,5Q2/26
4.Margins & cost structure
%31.5%Q2/26
5.Returns & cash cycle
% · days38.2%Q2/26
6.Earnings quality & cash
VND bn21,5Q2/26
7.Asset structure
VND bn92,7Q2/26
8.Funding & debt health
VND bn · times92,7Q2/26
9.Revenue backlog
VND bn4,69Q2/26
10.Valuation
times · %7,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.630Q2/26
Adjusted EPS growth, latest quarter
41.4%
Average adjusted EPS growth, 3 quarters
15.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26